Clinical Trial Update: Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

View source ↗

Summary

A completed study comparing cardiovascular outcomes of GLP-1 receptor agonists versus insulin in individuals with early-onset type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Dulaglutide (dulaglutide)
• EXENATIDE (EXENATIDE)
• OZEMPIC (semaglutide)
• TRULICITY (DULAGLUTIDE)
• Victoza (Liraglutide)
• liraglutide (liraglutide)
• semaglutide (semaglutide)

Snippet

Sponsor: Karolinska Institutet | Conditions: Type 2 Diabetes Mellitus (T2DM) | Status: COMPLETED